Last reviewed · How we verify
NCT06142734
Laparoscopic Versus Open Pyeloplasty for Treatment of UPJO in Children.
NA trial testing pyeloplasty in Pyeloplasty in 40 participants. Status unknown.
1 January 2026
Quick facts
| Lead sponsor | Ahmed Mahmoud Abdelraouf |
|---|---|
| Phase | NA |
| Status | Status unknown |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 40 |
| Start date | 1 January 2024 |
| Primary completion | 1 January 2026 |
| Estimated completion | 1 January 2026 |
Drugs / interventions tested
- pyeloplasty
Conditions studied
- Pyeloplasty — all drugs for Pyeloplasty →
Sponsor
Ahmed Mahmoud Abdelraouf
Who can join
Adults 1 to 18, any sex, with Pyeloplasty. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Uretropelvic junction ( UPJ ) obstruction is a common congenital disorder , but not all cases require surgical intervention. Uretropelvic junction ( UPJ ) obstruction is a common congenital disorder , but not all cases require surgical intervention. On the other hand, in children many authors reported mini incision open pyeloplasty with very small subcostal muscle splitting incision, with negligible postoperative pain and very short hospital stay
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT06142734
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of pyeloplasty
Trials testing the same drug.
- NCT05895422 — Functional Outcome After Minimally Invasive Pyeloplasty for Adult Patients With UPJO · Phase 3 · unknown
Other recruiting trials for Pyeloplasty
Currently open trials in the same condition.
- NCT06847841 — Cost-Effectiveness and Clinical Outcomes of Double J Stent Versus Percutaneous Feeding Tube Placement Following Open Pye · NA · active not recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06142734 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Ahmed Mahmoud Abdelraouf
- Last refreshed: 21 November 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06142734.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing